Vaccine Development

Technology Invented for Cancer and Infectious Diseases

Published in Vaccine Weekly, October 26th, 1998

Immunomedics, Inc., Morris Plains, New Jersey, announced the issuance of a U.S. patent to the company covering vaccines that evoke immune responses against tumor cells and infectious agents.

According to the inventor, Dr. Hans J. Hansen, Immunomedics, "The invention is called a 'multi-stage cascade boosting vaccine,' because it combines two vaccine technologies with certain cytokines, whereby the anticancer or anti-infection antibodies are given first, followed by anti-idiotype vaccines that mimic the cancer or infectious agent against which immunity is desired."

The patent also describes the enhancement of cellular immunity, involving T-lymphocytes,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1998-10-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry